메뉴 건너뛰기




Volumn 76, Issue 2, 2014, Pages 305-309

Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 6; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER;

EID: 84907597533     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24208     Document Type: Article
Times cited : (50)

References (20)
  • 1
    • 33745334334 scopus 로고    scopus 로고
    • Revised diagnostic criteria for neuromyelitis optica
    • Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
    • (2006) Neurology , vol.66 , pp. 1485-1489
    • Wingerchuk, D.M.1    Lennon, V.A.2    Pittock, S.J.3
  • 2
    • 10344250945 scopus 로고    scopus 로고
    • A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis
    • Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
    • (2004) Lancet , vol.364 , pp. 2106-2112
    • Lennon, V.A.1    Wingerchuk, D.M.2    Kryzer, T.J.3
  • 3
    • 23944444890 scopus 로고    scopus 로고
    • IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
    • Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
    • (2005) J Exp Med , vol.202 , pp. 473-477
    • Lennon, V.A.1    Kryzer, T.J.2    Pittock, S.J.3
  • 4
    • 0036310181 scopus 로고    scopus 로고
    • A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
    • Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-1461.
    • (2002) Brain , vol.125 , pp. 1450-1461
    • Lucchinetti, C.F.1    Mandler, R.N.2    McGavern, D.3
  • 5
    • 34249711828 scopus 로고    scopus 로고
    • Loss of aquaporin 4 in lesions of neuromyelitis optica: Distinction from multiple sclerosis
    • Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007; 130: 1224-1234.
    • (2007) Brain , vol.130 , pp. 1224-1234
    • Misu, T.1    Fujihara, K.2    Kakita, A.3
  • 6
    • 77954982900 scopus 로고    scopus 로고
    • Astrocytic damage is far more severe than demyelination in NMO: A clinical CSF biomarker study
    • Takano R, Misu T, Takahashi T, et al. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 2010; 75: 208-216.
    • (2010) Neurology , vol.75 , pp. 208-216
    • Takano, R.1    Misu, T.2    Takahashi, T.3
  • 7
    • 1542395857 scopus 로고    scopus 로고
    • CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
    • Narikawa K, Misu T, Fujihara K, et al. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 2004; 149: 182-186.
    • (2004) J Neuroimmunol , vol.149 , pp. 182-186
    • Narikawa, K.1    Misu, T.2    Fujihara, K.3
  • 8
    • 78650092261 scopus 로고    scopus 로고
    • Cytokine and chemokine profiles in neuromyelitis optica: Significance of interleukin-6
    • Uzawa A, Mori M, Arai K, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 2010; 16: 1443-1452.
    • (2010) Mult Scler , vol.16 , pp. 1443-1452
    • Uzawa, A.1    Mori, M.2    Arai, K.3
  • 9
    • 84876337808 scopus 로고    scopus 로고
    • Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis
    • Matsushita T, Tateishi T, Isobe N, et al. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PLoS One 2013; 8: e61835.
    • (2013) PLoS One , vol.8
    • Matsushita, T.1    Tateishi, T.2    Isobe, N.3
  • 10
    • 84879114145 scopus 로고    scopus 로고
    • Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders
    • Sato DK, Nakashima I, Takahashi T, et al. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013; 80: 2210-2216.
    • (2013) Neurology , vol.80 , pp. 2210-2216
    • Sato, D.K.1    Nakashima, I.2    Takahashi, T.3
  • 11
    • 72949114659 scopus 로고    scopus 로고
    • Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
    • Bradl M, Misu T, Takahashi T, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009; 66: 630-643.
    • (2009) Ann Neurol , vol.66 , pp. 630-643
    • Bradl, M.1    Misu, T.2    Takahashi, T.3
  • 12
    • 77249090731 scopus 로고    scopus 로고
    • Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
    • Saadoun S, Waters P, Bell BA, et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010; 133: 349-361.
    • (2010) Brain , vol.133 , pp. 349-361
    • Saadoun, S.1    Waters, P.2    Bell, B.A.3
  • 13
    • 85005784401 scopus 로고    scopus 로고
    • Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
    • Kitic M, Hochmeister S, Wimmer I, et al. Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta Neuropathol Commun 2013; 1: 5.
    • (2013) Acta Neuropathol Commun , vol.1 , pp. 5
    • Kitic, M.1    Hochmeister, S.2    Wimmer, I.3
  • 14
    • 84876144943 scopus 로고    scopus 로고
    • CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
    • Uzawa A, Mori M, Masuda S, et al. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica. J Neurol Neurosurg Psychiatry 2013; 84: 517-522.
    • (2013) J Neurol Neurosurg Psychiatry , vol.84 , pp. 517-522
    • Uzawa, A.1    Mori, M.2    Masuda, S.3
  • 15
    • 79952762854 scopus 로고    scopus 로고
    • Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
    • Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA 2011; 108: 3701-3706.
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 3701-3706
    • Chihara, N.1    Aranami, T.2    Sato, W.3
  • 16
    • 0031975888 scopus 로고    scopus 로고
    • Generation of plasma cells from peripheral blood memory B cells: Synergistic effect of interleukin-10 and CD27/CD70 interaction
    • Agematsu K, Nagumo H, Oguchi Y, et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood 1998; 91: 173-180.
    • (1998) Blood , vol.91 , pp. 173-180
    • Agematsu, K.1    Nagumo, H.2    Oguchi, Y.3
  • 17
    • 72949093353 scopus 로고    scopus 로고
    • Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica
    • Bennett JL, Lam C, Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009; 66: 617-629.
    • (2009) Ann Neurol , vol.66 , pp. 617-629
    • Bennett, J.L.1    Lam, C.2    Kalluri, S.R.3
  • 18
    • 84892425327 scopus 로고    scopus 로고
    • Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica
    • Chihara N, Aranami T, Oki S, et al. Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. PLoS One 2013; 8: e83036.
    • (2013) PLoS One , vol.8
    • Chihara, N.1    Aranami, T.2    Oki, S.3
  • 19
    • 84880844455 scopus 로고    scopus 로고
    • Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
    • Araki M, Aranami T, Matsuoka T, et al. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol 2013; 23: 827-831.
    • (2013) Mod Rheumatol , vol.23 , pp. 827-831
    • Araki, M.1    Aranami, T.2    Matsuoka, T.3
  • 20
    • 84862787794 scopus 로고    scopus 로고
    • Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica
    • Tradtrantip L, Zhang H, Saadoun S, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012; 71: 314-322.
    • (2012) Ann Neurol , vol.71 , pp. 314-322
    • Tradtrantip, L.1    Zhang, H.2    Saadoun, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.